Gonorrhoea

Despite global efforts to control gonorrhoea, several challenges and emerging trends persist. One major concern is the rise of antibiotic resistance in Neisseria gonorrhoeae. Over the years, the bacterium has demonstrated resistance to multiple classes of antibiotics, making treatment more challenging. The World Health Organization (WHO) emphasizes the importance of surveillance to monitor resistance patterns and guide treatment recommendations. The development of new antibiotics and alternative treatment strategies is crucial in the face of diminishing treatment options. Gonorrhoea disproportionately affects certain populations, including men who have sex with men (MSM), sex workers, and individuals with limited access to healthcare. Stigma, discrimination, and inadequate awareness of STI prevention contribute to the persistence of gonorrhoea in these populations. Comprehensive strategies for gonorrhoea control include promoting safe sexual practices, increasing access to testing and treatment, and integrating STI prevention into broader sexual health initiatives. The development of a gonorrhoea vaccine is an area of active research, aiming to provide long-term protection against infection. Global collaboration and continued research efforts are essential in addressing the evolving challenges posed by gonorrhoea and ensuring effective control measures in diverse populations.

Related Sessions